Φαρμακευτικο Μαρκετινγκ: Θεωρια, Πρακτικη, Δεοντολογια

The ultimate guide for Pharma Marketing Champions

Ζητήστε το στα κεντρικά βιβλιοπωλεία ή δώστε την παραγγελία σας τώρα…

http://www.stamoulis.gr/ViewShopProduct.aspx?ProductId=402023

The Next Revolution in Healthcare

Forbs | By Dan Riskin, MD

Dan Riskin lecturing at FutureMed at Singularity University in 2011.

Every 50 years, there is a revolution in healthcare based on the trends of the era. In the 1870s, healthcare was revolutionized by the germ theory of disease and promotion of public health efforts. In the 1920s, the discovery of penicillin propelled forward the use of medication as treatment for disease. In the 1970s, use of the randomized controlled trial (RCT) ushered in an era of evidence-based medicine. As we approach the 2020’s, the trend toward big data, tools and systemization of care will revolutionize the way hospitals and physicians work and, most importantly, the way patients are treated.

The Top Phase III Disasters of 2012

Drug development is a tough business. Sometimes, just when you think you're getting to the pot at the end of the rainbow, you find the trap door one step away. It's not supposed to work that way. The further you get down the pipeline, the better your shot at success. By the end of Phase II, investigators are supposed to have a solid set of significant safety and efficacy data on humans. Phase III is where the big bets are made, based on good science and some unprecedented demands for new products.